Search Results - "Schipper, Matthew"

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma by Wahl, Daniel R, Stenmark, Matthew H, Tao, Yebin, Pollom, Erqi L, Caoili, Elaine M, Lawrence, Theodore S, Schipper, Matthew J, Feng, Mary

“…Data guiding selection of nonsurgical treatment of hepatocellular carcinoma (HCC) are lacking. We therefore compared outcomes between stereotactic body…”
Get full text

Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma by Sapir, Eli, Tao, Yebin, Schipper, Matthew J., Bazzi, Latifa, Novelli, Paula M., Devlin, Pauline, Owen, Dawn, Cuneo, Kyle C., Lawrence, Theodore S., Parikh, Neehar D., Feng, Mary

“…To conduct a large single-institution comparison of transarterial chemoembolization (TACE) and stereotactic body radiation therapy (SBRT) outcomes in similar…”
Get full text

Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer by Dess, Robert T, Sun, Yilun, Matuszak, Martha M, Sun, Grace, Soni, Payal D, Bazzi, Latifa, Murthy, Venkatesh L, Hearn, Jason W D, Kong, Feng-Ming, Kalemkerian, Gregory P, Hayman, James A, Ten Haken, Randall K, Lawrence, Theodore S, Schipper, Matthew J, Jolly, Shruti

“…Purpose Radiation therapy is a critical component in the care of patients with non-small-cell lung cancer (NSCLC), yet cardiac injury after treatment is a…”
Get full text

Survival Outcome After Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: A Meta-Analysis by Zheng, Xiangpeng, MD, PhD, Schipper, Matthew, PhD, Kidwell, Kelley, PhD, Lin, Jules, MD, Reddy, Rishindra, MD, Ren, Yanping, MD, Chang, Andrew, MD, Lv, Fanzhen, MD, Orringer, Mark, MD, Spring Kong, Feng-Ming, MD, PhD

“…Purpose This study compared treatment outcomes of stereotactic body radiation therapy (SBRT) with those of surgery in stage I non-small cell lung cancer…”
Get full text

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer by Cuneo, Kyle C, Morgan, Meredith A, Sahai, Vaibhav, Schipper, Matthew J, Parsels, Leslie A, Parsels, Joshua D, Devasia, Theresa, Al-Hawaray, Mahmoud, Cho, Clifford S, Nathan, Hari, Maybaum, Jonathan, Zalupski, Mark M, Lawrence, Theodore S

“…AZD1775 (adavosertib) is an inhibitor of the Wee1 kinase. In this study, we built on our preclinical studies to evaluate the safety and efficacy of AZD1775 in…”
Get full text

Comparison of Population-Based Observational Studies With Randomized Trials in Oncology by Soni, Payal D, Hartman, Holly E, Dess, Robert T, Abugharib, Ahmed, Allen, Steven G, Feng, Felix Y, Zietman, Anthony L, Jagsi, Reshma, Schipper, Matthew J, Spratt, Daniel E

“…Comparative efficacy research performed using population registries can be subject to significant bias. There is an absence of objective data demonstrating…”
Get full text

Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes by Hartman, Holly, Tamura, Roy N., Schipper, Matthew J, Kidwell, Kelley M.

“…Small sample, sequential, multiple assignment, randomized trials (snSMARTs) are multistage trials with the overall goal of determining the best treatment after…”
Get full text

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis by Gharzai, Laila A, Jiang, Ralph, Wallington, David, Jones, Gavin, Birer, Samuel, Jairath, Neil, Jaworski, Elizabeth M, McFarlane, Matthew R, Mahal, Brandon A, Nguyen, Paul L, Sandler, Howard, Morgan, Todd M, Reichert, Zachery R, Alumkal, Joshi J, Mehra, Rohit, Kishan, Amar U, Fizazi, Karim, Halabi, Susan, Schaeffer, Edward M, Feng, Felix Y, Elliott, David, Dess, Robert T, Jackson, William C, Schipper, Matthew J, Spratt, Daniel E

“…The international Intermediate Clinical Endpoints in Cancer of the Prostate working group has established metastasis-free survival as a surrogate for overall…”
Get full text

Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases by Jackson, William C., Tao, Yebin, Mendiratta-Lala, Mishal, Bazzi, Latifa, Wahl, Dan R., Schipper, Matthew J., Feng, Mary, Cuneo, Kyle C., Lawrence, Theodore S., Owen, Dawn

“…Stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA) are widely used therapies for the treatment of intrahepatic metastases; however,…”
Get full text

Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer: Beyond Sparing the Parotid Glands by Little, Michael, M.D, Schipper, Matthew, Ph.D, Feng, Felix Y., M.D, Vineberg, Karen, M.S, Cornwall, Craig, D.M.D, Murdoch-Kinch, Carol-Anne, D.D.S., Ph.D, Eisbruch, Avraham, M.D

“…Purpose To assess whether, in addition to sparing the parotid glands (PGs), xerostomia after chemotherapy plus intensity-modulated radiotherapy (chemo-IMRT)…”
Get full text

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality by Dess, Robert T, Hartman, Holly E, Mahal, Brandon A, Soni, Payal D, Jackson, William C, Cooperberg, Matthew R, Amling, Christopher L, Aronson, William J, Kane, Christopher J, Terris, Martha K, Zumsteg, Zachary S, Butler, Santino, Osborne, Joseph R, Morgan, Todd M, Mehra, Rohit, Salami, Simpa S, Kishan, Amar U, Wang, Chenyang, Schaeffer, Edward M, Roach, 3rd, Mack, Pisansky, Thomas M, Shipley, William U, Freedland, Stephen J, Sandler, Howard M, Halabi, Susan, Feng, Felix Y, Dignam, James J, Nguyen, Paul L, Schipper, Matthew J, Spratt, Daniel E

“…Black men are more likely to die of prostate cancer than white men. In men with similar stages of disease, the contribution of biological vs nonbiological…”
Get more information

Women in the Medical Physics Workforce: Insights from Membership Trends of the American Association of Physicists in Medicine, 1993 to 2023 by Rankin, Jillian, Bedrava, Jenna, Covington, Elizabeth, Johnson, Jennifer Lynn, Pollard-Larkin, Julianne, Schipper, Matthew J., Castillo, Richard, Woodward, Michael, Xing, Yan-Hong, Paradis, Kelly C.

“…Women remain underrepresented in medical physics in the United States, and determinants of persisting disparities remain unclear. Here, we performed a detailed…”
Get full text

Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics by Wilkie, Joel R., Mierzwa, Michelle L., Casper, Keith A., Mayo, Charles S., Schipper, Matthew J., Eisbruch, Avraham, Worden, Francis P., El Naqa, Issam, Viglianti, Benjamin L., Rosen, Benjamin S.

“…•Parotid PET features and dose are associated with late xerostomia and salivary flow.•Associations are strongest for patient-reported need to sip fluids while…”
Get full text

Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life by Hawkins, Peter G., Lee, Jae Y., Mao, Yanping, Li, Pin, Green, Michael, Worden, Francis P., Swiecicki, Paul L., Mierzwa, Michelle L., Spector, Matthew E., Schipper, Matthew J., Eisbruch, Avraham

“…While parotid-sparing intensity modulated radiotherapy (IMRT) has demonstrated superiority to conventional RT in terms of observer-rated xerostomia,…”
Get full text

Single-Time-Point Imaging for Dosimetry After [ 177 Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection by Wang, Chang, Peterson, Avery B, Wong, Ka Kit, Roseland, Molly E, Schipper, Matthew J, Dewaraja, Yuni K

“…Estimation of the time-integrated activity (TIA) for dosimetry from imaging at a single time point (STP) facilitates the clinical translation of…”
Get full text

Adaptive Phase 1 Design in Radiation Therapy Trials by Wages, Nolan A., Braun, Thomas M., Normolle, Daniel P., Schipper, Matthew J.

Get full text

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 by Prensner, John R, MD, Zhao, Shuang, MSc, Erho, Nicholas, MSc, Schipper, Matthew, PhD, Iyer, Matthew K, PhD, Dhanasekaran, Saravana M, PhD, Magi-Galluzzi, Cristina, MD, Mehra, Rohit, MD, Sahu, Anirban, BSc, Siddiqui, Javed, MSc, Davicioni, Elai, PhD, Den, Robert B, MD, Dicker, Adam P, Prof, Karnes, R Jeffrey, MD, Wei, John T, Prof, Klein, Eric A, Prof, Jenkins, Robert B, Prof, Chinnaiyan, Arul M, Prof, Feng, Felix Y, Dr

“…Summary Background Improved clinical predictors for disease progression are needed for localised prostate cancer, since only a subset of patients develop…”
Get full text

Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up by Mendiratta-Lala, Mishal, Masch, William, Shankar, Prasad R., Hartman, Holly E., Davenport, Matthew S., Schipper, Matthew J., Maurino, Chris, Cuneo, Kyle C., Lawrence, Theodore S., Owen, Dawn

“…To determine the natural history of imaging findings seen on magnetic resonance imaging (MRI) of hepatocellular carcinoma (HCC) treated with stereotactic body…”
Get full text

Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial by Feng, Mary, Suresh, Krithika, Schipper, Matthew J, Bazzi, Latifa, Ben-Josef, Edgar, Matuszak, Martha M, Parikh, Neehar D, Welling, Theodore H, Normolle, Daniel, Ten Haken, Randall K, Lawrence, Theodore S

“…Patients with preexisting liver dysfunction could benefit the most from personalized therapy for liver tumors to balance maximal tumor control and minimal risk…”
Get more information

In Regard to Lo et al by Cousins, Matthew M., Lawrence, Theodore S., Morris, Emily, Schipper, Matthew J., Cuneo, Kyle C.

Get full text